Alzheimers Disease Patient Registry
Alzheimers Disease Patient Registry
批准号:
8841434
负责人:
RONALD C PETERSEN
金额:
$13.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-30 至 2014-06-30
关键词:
AgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs Disease patient registryBiochemicalBiocompatible MaterialsBiological MarkersBlood VesselsCerebrospinal FluidCessation of lifeClinicClinicalClinical TrialsCognitionComorbidityCountyDementiaEtiologyFutureGenetic MarkersGenotypeGoalsGrantImageImpaired cognitionIncidenceIndividualInstructionMRI ScansMeasuresMedicalMedical Record LinkageModelingOutcomeOutcome StudyParticipantPersonsPittsburgh Compound-BPlasmaPopulationPrevalencePrincipal InvestigatorProcessPublic HealthResearch PersonnelResearch Project GrantsResourcesRisk FactorsRoleScanningSystemTechniquesTimeTrainingWomanclinical Diagnosiscohortdesigninvestigator trainingmenmild cognitive impairmentmortalityneuroimagingnovelpopulation basedsex
中文摘要
描述(由申请人提供):梅奥临床衰老研究(MCSA)于2004年在明尼苏达州奥姆斯特德县成立,是一项基于人群的衰老、轻度认知障碍(MCI)和痴呆研究。具体目的是估计正常认知、MCI及其亚型的人群患病率,估计MCI和痴呆的发病率,并开始探索这些疾病的预测因素。在拟议的更新期内,我们计划细化MCI和痴呆的发病率,并评估各种传统和新型因素的效用,包括医学合并症、生物标志物和影像学指标,以预测MCI和痴呆。我们提出以下具体目标:具体目标1:获得正常认知到轻度认知损伤、其亚型和痴呆的发病率的稳定估计,其亚型包括阿尔茨海默病,以及从轻度认知损伤到痴呆的性别和推定病因。具体目标2:调查从正常认知到轻度认知损伤和按性别和病因转变为痴呆的潜在危险因素或预测因素,包括临床、生化和影像学标志物,以及按性别和病因从轻度认知损伤到痴呆的潜在危险因素或预测因素。特异性目标3:探索特异性目标2导致的从正常认知到MCI和痴呆的性别和病因转变的风险因素或预测因素的多变量模型,以及MCI到痴呆的亚型和性别转变的多变量模型。具体目标4:为相关研究项目提供课题和生物材料,为新研究者的培养提供平台。为了实现这些目标,到提议的拨款启动时,目前的队列将补充到2000人(大约1650名认知正常和350名轻度认知障碍患者)。我们将使用梅奥诊所的医疗记录链接系统来验证医疗合并症,并评估其作为我们研究结果预测因素的作用。在拟议的拨款续期开始时,我们将完成对参与者的1500多个定量MRI扫描,并将对从队列中随机选择的600人进行脑脊液和匹兹堡化合物B扫描。这些指标将与年度血浆A(3)指标和基因型信息相结合,建立多变量预测模型。这项拟议的研究将首次尝试将临床、神经影像学和生物标志物信息结合起来,作为5 - 10年期间以非痴呆人群为基础的大型队列中认知障碍的预测因素。相关性(见说明):我们迫切需要技术来预测哪些个体将来会发展为轻度认知障碍和阿尔茨海默病(AD)。梅奥诊所衰老研究旨在探索常见和新型医疗危险因素、神经影像学测量和生物标志物在人群基础环境中预测AD的效用。这些信息对于公共卫生目的和预防阿尔茨海默病的临床试验计划至关重要。
英文摘要
DESCRIPTION (provided by applicant): The Mayo Clinic Study of Aging (MCSA) was established in 2004 as a population-based study of aging, mild cognitive impairment (MCI) and dementia in Olmsted County, MN. The specific aims were designed to estimate the population prevalence of normal cognition, MCI and its subtypes, to estimate incidence rates of MCI and dementia, and begin to explore predictors for these conditions. In the proposed renewal period, we plan to refine the incidence rates for MCI and dementia and to evaluate the utility of a variety of traditional and novel factors including medical comorbidities, biomarkers and imaging measures for predicting MCI and dementia. We propose the following specific aims: Specific Aim 1: To obtain stable estimates of incidence rates for normal cognition to MCI, its subtypes, and dementia, and its subtypes including Alzheimer's disease, and from MCI to dementia by sex and presumed etiology. Specific Aim 2: To investigate potential risk factors or predictors including clinical, biochemical and imaging markers for transitions from normal cognition to MCI and to dementia by sex and etiology, and from MCI to dementia by sex and etiology. Specific Aim 3: To explore multivariable models of risk factors or predictors resulting from Specific Aim 2 for transitions from normal cognition to MCI and dementia by sex and etiology and for MCI to dementia by subtypes and sex. Specific Aim 4: To provide subjects and biological materials for related research projects and provide a platform for training new investigators. To accomplish these goals, the current cohort will be replenished to 2000 persons (approximately 1650 cognitively normal and 350 MCI) by the time of the proposed grant initiation. We will use the Mayo Clinic medical records-linkage system to validate medical comorbidities and evaluate their role as predictors for our study outcomes. At the initiation of the proposed grant renewal period, we will have completed over 1500 quantitative MRI scans on the participants and will be in the process of obtaining cerebrospinal fluid and Pittsburgh Compound B scans on 600 persons randomly selected from the cohort. These measures will be combined with annual plasma A (3 measures and genotype information to develop multivariable prediction models. This proposed study will represent one of the first attempts to combine clinical, neuroimaging and biomarker information as predictors of cognitive impairment in a large non-demented population-based cohort over a period of 5 - 10 years. RELEVANCE (See instructions): We urgently need techniques to predict which individuals will develop mild cognitive impairment and Alzheimer's disease (AD) in the future. The Mayo Clinic Study of Aging is designed to explore the utility of common and novel medical risk factors, neuroimaging measures and biomarkers to predict AD in a population-based setting. This information is essential for public health purposes and for the planning of clinical trials for the prevention of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MarkVCID Validation in the General Community
-
批准号:10364014
-
项目类别:
-
资助金额:$245.42万
-
财政年份:2021
-
负责人:RONALD C PETERSEN
-
依托单位:
MarkVCID Validation in the General Community
-
批准号:10619433
-
项目类别:
-
资助金额:$364.68万
-
财政年份:2021
-
负责人:RONALD C PETERSEN
-
依托单位:
Administrative Core
-
批准号:10413830
-
项目类别:
-
资助金额:$57.77万
-
财政年份:2019
-
负责人:RONALD C PETERSEN
-
依托单位:
Administrative Core
-
批准号:10657550
-
项目类别:
-
资助金额:$61.06万
-
财政年份:2019
-
负责人:RONALD C PETERSEN
-
依托单位:
Mayo Alzheimer's Disease Research Center
-
批准号:10413829
-
项目类别:
-
资助金额:$300.45万
-
财政年份:2019
-
负责人:RONALD C PETERSEN
-
依托单位:
Mayo Alzheimer's Disease Research Center
-
批准号:10657549
-
项目类别:
-
资助金额:$321.81万
-
财政年份:2019
-
负责人:RONALD C PETERSEN
-
依托单位:
Mayo Alzheimer's Disease Research Center Supplement (Identification and measurement of influences on brain donation decision making in African Americans)
-
批准号:10602684
-
项目类别:
-
资助金额:$24.04万
-
财政年份:2019
-
负责人:RONALD C PETERSEN
-
依托单位:
CLINICAL CORE
-
批准号:7624820
-
项目类别:
-
资助金额:$65.83万
-
财政年份:2009
-
负责人:RONALD C PETERSEN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7624819
-
项目类别:
-
资助金额:$14.45万
-
财政年份:2009
-
负责人:RONALD C PETERSEN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:6798065
-
项目类别:
-
资助金额:$9.4万
-
财政年份:2004
-
负责人:RONALD C PETERSEN
-
依托单位:
MAYO ALZHEIMERS DISEASE RESEARCH CENTER
-
批准号:6788404
-
项目类别:
-
资助金额:$7.16万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
MAYO ALZHEIMERS DISEASE RESEARCH CENTER
-
批准号:6631492
-
项目类别:
-
资助金额:$173.41万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
MAYO ALZHEIMERS DISEASE RESEARCH CENTER
-
批准号:6509781
-
项目类别:
-
资助金额:$182.4万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
Mayo Alzheimer's Disease Research Center
-
批准号:7283853
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
Mayo Alzheimer's Disease Research Center
-
批准号:7065699
-
项目类别:
-
资助金额:$185.61万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
Mayo Alzheimer's Disease Research Center
-
批准号:8676245
-
项目类别:
-
资助金额:$195.71万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
Mayo Alzheimer's Disease Research Center
-
批准号:8065956
-
项目类别:
-
资助金额:$191.84万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
MAYO ALZHEIMERS DISEASE RESEARCH CENTER
-
批准号:2800072
-
项目类别:
-
资助金额:$120.05万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
ALZHEIMERS DISEASE RESEARCH CENTER
-
批准号:6092306
-
项目类别:
-
资助金额:$3.35万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
MAYO ALZHEIMERS DISEASE RESEARCH CENTER
-
批准号:6132417
-
项目类别:
-
资助金额:$9.0万
-
财政年份:1999
-
负责人:RONALD C PETERSEN
-
依托单位:
海外基金